News & Resources

KNOWLEDGE AND INSIGHTS

News & Resources

KNOWLEDGE AND INSIGHTS
News & Resources2023-12-11T12:21:39-05:00

Our attorneys submit legal updates, professional articles and newsletters of interest to our clients. Many of our lawyers are called upon to speak at professional events and provide their expertise. We are pleased to share our insights, news items and other information of use to our clients.

Defending the Hotel Website Discrimination Lawsuit

February 18, 2021|

In the past several months, a rash of lawsuits have been filed in federal district courts throughout New England, and indeed, throughout the country, by plaintiffs claiming that they have been subjected to discrimination by hotels.  The lawsuits have specifically focused upon alleged shortcomings in hotel websites, and the plaintiffs [...]

Cybersecurity, Privacy and Data Protection – 2/10/21

February 10, 2021|

In this edition of the Cybersecurity Newsletter, our team discusses the policy language that made a $900,000 difference in cyber insurance coverage for one company that fell victim to a social engineering attack, the importance of vendor contracts spelling out what happens to the client’s data upon termination of the [...]

Prepping for the PREP Act: An Analysis of Litigation Limitations Due to COVID-19

February 9, 2021|

2020 was unprecedented.  The COVID-19 pandemic brought the world to a stop.  Medical providers from community colleges through Ivy League schools banded together to treat and overcome the unparalleled devastation COVID-19 caused.  Nursing homes were among the hardest hit as the virus had a higher mortality rate for the elderly.  [...]

MA Appellate Practice and Procedure Bulletin – February 2021

February 2, 2021|

Morrison Mahoney partner Tory A. Weigand comments on the Supreme Judicial Court’s recent decision in Dunn v. Genzyme (January 29, 2021) where the High Court addressed the conflict and differing views as to the level of specificity needed to plead state law product liability claims as to a FDA approved medical device in order to survive a motion to dismiss based on federal preemption and the plausibility standard under Rule 12(b)(6).

Thought Leaders

We regularly share our knowledge with our clients through customized educational seminars. Many of us are nationally recognized speakers in our fields, having served as faculty for programs produced around the world.

Go to Top